Stock ZOTA ZOTA HEALTH CARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zota Health Care Limited

Equities

ZOTA

INE358U01012

Pharmaceuticals

Delayed NSE India S.E.
Other stock markets
 05:58:23 2024-05-08 am EDT 		5-day change 1st Jan Change
475.2 INR +0.31% Intraday chart for Zota Health Care Limited -2.14% +0.58%
Mar. 08 Zota Health Care Limited Announces Resignation of Manukant Chandulal Zota as Whole-Time Director, Effective March 31, 2024 CI
Feb. 08 Zota Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Valuation

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Capitalization 1 3,770 4,556 3,199 3,402 7,488 7,089
Enterprise Value (EV) 1 3,745 4,539 3,191 3,388 7,614 7,529
P/E ratio 50.8 x 82.2 x 117 x -1,539 x 83.1 x -123 x
Yield 1.4% 0.39% 0.77% 0.72% 0.5% 0.35%
Capitalization / Revenue 4.84 x 5.32 x 3.36 x 3.17 x 5.7 x 5.04 x
EV / Revenue 4.81 x 5.3 x 3.35 x 3.16 x 5.8 x 5.35 x
EV / EBITDA 34.4 x 57.8 x 69.5 x 352 x 54.1 x 2,657 x
EV / FCF -95.1 x -68.2 x -298 x -146 x 97.4 x -50.9 x
FCF Yield -1.05% -1.47% -0.34% -0.69% 1.03% -1.97%
Price to Book 5.4 x 6.61 x 4.65 x 5.13 x 8.35 x 8.82 x
Nbr of stocks (in thousands) 24,561 24,561 24,560 24,560 25,160 25,160
Reference price 2 153.5 185.5 130.2 138.5 297.6 281.8
Announcement Date 8/16/18 8/28/19 8/30/20 9/2/21 9/5/22 9/13/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net sales 1 778.5 856.3 951.8 1,072 1,313 1,408
EBITDA 1 109 78.56 45.91 9.613 140.7 2.834
EBIT 1 99.66 64.74 25.32 -21.29 112 -38.27
Operating Margin 12.8% 7.56% 2.66% -1.99% 8.54% -2.72%
Earnings before Tax (EBT) 1 113.4 78.56 38.62 -3.654 124.3 -46.91
Net income 1 72.68 55.48 27.42 -2.089 89.08 -57.73
Net margin 9.34% 6.48% 2.88% -0.19% 6.79% -4.1%
EPS 2 3.019 2.257 1.116 -0.0900 3.580 -2.294
Free Cash Flow 1 -39.4 -66.57 -10.69 -23.23 78.14 -148
FCF margin -5.06% -7.77% -1.12% -2.17% 5.95% -10.52%
FCF Conversion (EBITDA) - - - - 55.52% -
FCF Conversion (Net income) - - - - 87.73% -
Dividend per Share 2 2.143 0.7143 1.000 1.000 1.500 1.000
Announcement Date 8/16/18 8/28/19 8/30/20 9/2/21 9/5/22 9/13/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - 126 440
Net Cash position 1 24.6 16.9 8.35 13.2 - -
Leverage (Debt/EBITDA) - - - - 0.8953 x 155.3 x
Free Cash Flow 1 -39.4 -66.6 -10.7 -23.2 78.1 -148
ROE (net income / shareholders' equity) 15% 8% 3.98% -0.31% 11.4% -6.79%
ROA (Net income/ Total Assets) 8.56% 4.46% 1.78% -1.53% 6.24% -1.61%
Assets 1 849.4 1,244 1,543 136.6 1,428 3,587
Book Value Per Share 2 28.40 28.10 28.00 27.00 35.60 31.90
Cash Flow per Share 2 1.000 0.6900 0.3400 0.5400 0.9100 0.4400
Capex 1 4.27 16.1 8.27 6.25 32.5 125
Capex / Sales 0.55% 1.88% 0.87% 0.58% 2.47% 8.88%
Announcement Date 8/16/18 8/28/19 8/30/20 9/2/21 9/5/22 9/13/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
ZOTA HEALTH CARE LIMITED Stock Zota Health Care Limited
+0.58% 143M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+33.43% 700B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.56% 569B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.12% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.59% 330B
ABBVIE INC. Stock AbbVie Inc.
+4.89% 287B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.53% 236B
NOVARTIS AG Stock Novartis AG
+6.81% 202B
ROCHE HOLDING AG Stock Roche Holding AG
-9.12% 197B
AMGEN INC. Stock Amgen Inc.
+4.26% 161B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ZOTA Stock
  4. Financials Zota Health Care Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW